2459 related articles for article (PubMed ID: 7753552)
1. Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene.
Brown AD; Lopez-Terrada D; Denny C; Lee KA
Oncogene; 1995 May; 10(9):1749-56. PubMed ID: 7753552
[TBL] [Abstract][Full Text] [Related]
2. MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription.
Li KK; Lee KA
Oncogene; 1998 Mar; 16(10):1325-31. PubMed ID: 9546434
[TBL] [Abstract][Full Text] [Related]
3. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator.
Fujimura Y; Ohno T; Siddique H; Lee L; Rao VN; Reddy ES
Oncogene; 1996 Jan; 12(1):159-67. PubMed ID: 8552387
[TBL] [Abstract][Full Text] [Related]
4. The cellular oncogene EWS/activating transcription factor 1 is unable to activate adenovirus-borne promoters: implications for cytotoxic prodrug therapy of malignant melanoma of soft parts.
Lung RW; Lee KA
Cancer Gene Ther; 2000 Mar; 7(3):396-406. PubMed ID: 10766345
[TBL] [Abstract][Full Text] [Related]
5. Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation.
Speleman F; Delattre O; Peter M; Hauben E; Van Roy N; Van Marck E
Mod Pathol; 1997 May; 10(5):496-9. PubMed ID: 9160316
[TBL] [Abstract][Full Text] [Related]
6. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour.
Lee SB; Kolquist KA; Nichols K; Englert C; Maheswaran S; Ladanyi M; Gerald WL; Haber DA
Nat Genet; 1997 Nov; 17(3):309-13. PubMed ID: 9354795
[TBL] [Abstract][Full Text] [Related]
7. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
Lessnick SL; Braun BS; Denny CT; May WA
Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
[TBL] [Abstract][Full Text] [Related]
8. The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly.
Pan S; Ming KY; Dunn TA; Li KK; Lee KA
Oncogene; 1998 Mar; 16(12):1625-31. PubMed ID: 9569031
[TBL] [Abstract][Full Text] [Related]
9. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.
Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ
Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340
[TBL] [Abstract][Full Text] [Related]
10. Cloning and chromosome localization of the mouse Ews gene.
Plougastel B; Mattei MG; Thomas G; Delattre O
Genomics; 1994 Sep; 23(1):278-81. PubMed ID: 7829090
[TBL] [Abstract][Full Text] [Related]
11. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
Panagopoulos I; Höglund M; Mertens F; Mandahl N; Mitelman F; Aman P
Oncogene; 1996 Feb; 12(3):489-94. PubMed ID: 8637704
[TBL] [Abstract][Full Text] [Related]
12. ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element.
Guo B; Stein JL; van Wijnen AJ; Stein GS
Biochemistry; 1997 Nov; 36(47):14447-55. PubMed ID: 9398163
[TBL] [Abstract][Full Text] [Related]
13. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
14. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains.
Ohno T; Ouchida M; Lee L; Gatalica Z; Rao VN; Reddy ES
Oncogene; 1994 Oct; 9(10):3087-97. PubMed ID: 8084618
[TBL] [Abstract][Full Text] [Related]
15. Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins.
Morohoshi F; Arai K; Takahashi EI; Tanigami A; Ohki M
Genomics; 1996 Nov; 38(1):51-7. PubMed ID: 8954779
[TBL] [Abstract][Full Text] [Related]
16. Identification of target genes for EWS/ATF-1 chimeric transcription factor.
Jishage M; Fujino T; Yamazaki Y; Kuroda H; Nakamura T
Oncogene; 2003 Jan; 22(1):41-9. PubMed ID: 12527906
[TBL] [Abstract][Full Text] [Related]
17. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.
Crozat A; Aman P; Mandahl N; Ron D
Nature; 1993 Jun; 363(6430):640-4. PubMed ID: 8510758
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays.
Schaefer KL; Wai DH; Poremba C; Korsching E; van Valen F; Ozaki T; Boecker W; Dockhorn-Dworniczak B
Virchows Arch; 2002 May; 440(5):476-84. PubMed ID: 12021921
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
20. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
Prasad DD; Ouchida M; Lee L; Rao VN; Reddy ES
Oncogene; 1994 Dec; 9(12):3717-29. PubMed ID: 7970732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
